Doubt about the feasibility of preemptive genotyping

2013-03-01

Additional Metadata
Keywords	adjuvant therapy, breast cancer, cancer adjuvant therapy, genotype, letter, pharmacogenetics, priority journal
Persistent URL	doi.org/10.1038/clpt.2012.191, hdl.handle.net/1765/40021
Journal	Clinical Pharmacology and Therapeutics
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Koch, B., van Schaik, R., van Gelder, T., & Mathijssen, R. (2013). Doubt about the feasibility of preemptive genotyping. Clinical Pharmacology and Therapeutics, 93(3). doi:10.1038/clpt.2012.191

Publication